Therapeutic Update 2024

Therapeutic Update 2024

 

Find University Learning System On Social Media


Exhibit

Symposia

Workshops

Organiser

Sponsor



Don't miss the legendary Dr. C. Wayne Weart presenting the annual New Drug Update in Key West. Join us in Key West at the luxurious Hyatt Centric Key West Resort & Spa. This conference is a popular CE/CME program which provides 15 contact hours (1.5 CEU) of live AAFP/ AMA PRA Category 1 Credit™, ACPE pharmacology CE/CME credit

Conference Credit


PHARMACISTS :University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists.

Session

Contact Hours

ACPE UAN

Activity

Session 1

50741-0000-23-0011-L08-PAPPLICATION
Session 250741-0000-23-0011-L09-PAPPLICATION
Session 350741-0000-23-0011-L10-PKNOWLEDGE

NURSE PRACTITIONERS/ NURSES: This course provides 15 contact hours (1.5 CEU) over three days, 5 hours per day, to fulfill the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours for certification renewal. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).


PHYSICIANS: Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. CME programs approved by the AAFP are eligible for Category 2 credit (or Category 1-A under special circumstances) through the American Osteopathic Association (AOA).


PHYSICIAN ASSISTANTS: American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program.


CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.


CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.


CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.


OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval

Conference Registration


Option

3 Day Fee

2 Day Fee

1 Day Fee

Live Stream$550$398$199

Discounted Advanced Registration
Expires March 23, 2024

$725 n/a n/a
Regular Registration$750 n/a n/a
Advanced Registration NOT Staying at Hyatt$925 n/a n/a
Regular Registration NOT Staying at Hyatt$950 n/a n/a

In Person Conference Registration: Conference registration includes workshop attendance, handouts, breakfast or refreshments during the meetings and documentation of continuing education credit. Spouses, family and friends are welcome and do not need to register unless they attend the educational sessions. Special seminar fees are available for non-professional accompanying persons who wish to attend one or more session (no special receipt, certification or credit issued).


Live Stream Webcast Registration: Includes live conference streaming, access to online course materials and documentation of continuing education credit.


Zoom Requires: An internet connection – broadband wired or wireless (3G or 4G/LTE) For More info: https://support.zoom.us/hc/en-us/ articles/201362023-Zoom-system-requirements-Windows-macOS-Linux


Requirements For Credit: Credit is dependent on verification of conference attendance by on-time check-in at each session and ULS receipt of completed evaluations. Credit is determined based on actual attendance on a per session basis, no partial credit is awarded.


Pharmacists: Please ensure that we have your NABP# and date of birth on file. ACPE does not allow us to provide you with paper statements of credit.


Statements of Credit: Should you need a paper statement of credit, you can access that information via CPE Monitor. All other professionals: An applicable paper Statement of Credit will be issued upon receipt of your post-conference paperwork.


Requirements For Credit: Credit is dependent on verification of conference attendance by on-time check-in at each session and ULS receipt of completed evaluations. Credit is determined based on actual attendance on a per session basis, no partial credit is awarded.


Note: Approximately one 15 minute break per 2.5 hours. Credited hours do not include breaks.

Educational Sessions


  • April 23 ,2024 - New Drug Update Part 1

    Tuesday, April 23, 2024: 7:30 AM - 8:00 AM Registration & Breakfast, 8:00 AM - 1:30PM Educational Program

    New Drug Update Part 1

    At the completion of this activity, the participant will be able to:

    1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.

    2. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.

    3. Describe their adverse effects and drug interaction that may affect patient compliance.

    4. Compare efficacy, dosage and cost to existing agents.

    5. Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients.

    6. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.

  • April 24, 2024 -New Drug Update Part 2

    Wednesday, April 24, 2024 7:30 AM - 8:00 AM Registration & Breakfast, 8:00 AM - 1:30PM Educational Program

    New Drug Update Part 2

    At the completion of this activity, the participant will be able to:

    1. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.

    2. Describe their adverse effects and drug interaction that may affect patient compliance. 3. Compare efficacy, dosage and cost to existing agents.

    3. Compare efficacy, dosage and cost to existing agents.

    4. Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients.

    5. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.

  • April 25, 2024 - Practical Application of the CDC Clinical Practice Guidelines for Prescribing Opioids

    Thursday, April 25, 2024: 7:30AM - 8:00 AM Registration & Breakfast, 8:00 AM - 1:30PM Educational Program

    Practical Application of the CDC Clinical Practice Guidelines for Prescribing Opioids

    1. Describe the key therapeutic goals of the 2022 Proposed CDC Recommendations/Guidelines for prescribing opioids for outpatients.

    2. Describe the fundamental concepts of pain management, including definitions such as: a) addiction; b) tolerance; c) dependency; d) hyperalgesia; e) allodynia.

    3. State key principles for assessing patients in pain, identifying risk factors and behaviors that are associated with opioid misuse, abuse, and addiction.

    4. State examples of therapeutic options for managing pain, including nonpharmacologic options and pharmacologic (nonopioid and opioid analgesic) therapies.

    5. Compare and contrast the risks and benefits for utilizing opioid therapy for acute and chronic pain and state how and when to follow-up when patients are prescribed opioid analgesics.

    6. State the main characteristics of patients who would be identified as "high risk", "moderate risk" and "low risk" for chronic opioid use.

    7. State how to manage patients safely and effectively on opioid analgesics in the acute and chronic pain settings, including initiating therapy, titrating, and discontinuing use of opioid analgesics.

    8. Define a reasonable quantity of opioids to prescribe / dispense to a patient with acute pain and chronic non-cancer pain.

    9. Describe how to counsel patients and caregivers regarding the safe use on naloxone for opioid overdose.

    10. State key educational principles that should be applied to all patients and caregivers regarding the safe use of opioid analgesics, including, proper storage and disposal.




Related articles

More events

Annual Isokinetic Conference 2024

Sat, 25 May 2024 - Mon, 27 May 2024


Av. de Luis Aragonés, 4, San Blas-Canillejas
Madrid, 28022
Spain
XXVI IFCC WorldLab Congress 2024

Sun, 26 May 2024 - Thu, 30 May 2024


Sheikh Zayed Rd - Trade Centre 2
Dubai,
United Arab Emirates
2024 ACSM Annual Meeting

Tue, 28 May 2024 - Fri, 31 May 2024


900 Boylston St
Boston, MA 02115
United States
Future Health Summit 2024

Wed, 29 May 2024 - Thu, 30 May 2024


Ship Street Great, Le Pole Square 1
Dublin D08 E6PD
Ireland